Učitavanje...
Development of Second-Generation VEGFR Tyrosine Kinase Inhibitors: Current Status
The vascular endothelial growth factor (VEGF) signaling pathway appears to be the dominant pathway involved in tumor angiogenesis, providing a rationale for targeting the VEGF receptors (VEGFR-1, -2, and -3) in the treatment of cancers. In particular, VEGF signaling is thought to be important in ren...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Current Science Inc.
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047052/ https://ncbi.nlm.nih.gov/pubmed/21318618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-011-0154-3 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|